drugset
Drugs / aTIV
last change Jul 2021 re-read 3 minutes ago

aTIV

Vaccine

Developed for
influenza
Investigated by
CHU de Quebec-Universite Laval · Canadian Center for Vaccinology · Canadian Immunization Research Network · Dalhousie University · McGill University Health Centre/Research Institute of the McGill University Health Centre · Provincial Health Services Authority British Columbia
+1 more · University of Montreal

Trials 1

today NCT03669627 · Ph 2
20192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT03669627 Nov 2018 → Jul 2021 influenza Canadian Immunization Research Network Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as aTIV ClinicalTrials.gov intervention name — accepted as the source's own label NCT03669627 ↗
Modality Vaccine “MF59-adjuvanted trivalent influenza vaccine” NCT03669627 ↗